Supplementary Legal Opinion (10) on the Initial Public Offering and Listing of Ciming Health Checkup Management Group Co., Ltd.
Beijing Tianda Law Firm (hereinafter referred to as "this firm") has been entrusted by Ciming Health Checkup Management Group Co., Ltd. (hereinafter referred to as "the company" or "the issuer") to act as special legal counsel for the company's initial public offering of RMB ordinary shares and listing (hereinafter referred to as "this issuance" or "this issuance and listing").
This firm has conducted an investigation based on the requirements of the China Securities Regulatory Commission (hereinafter referred to as "CSRC") regarding the verification of issues raised in a complaint letter concerning Ciming Health Checkup Management Group Co., Ltd. (Issuance Supervision Letter [2012] No. 381). The supplementary legal opinion is as follows:
Please have the sponsor institution and the issuer's lawyers verify whether the following matters raised by the complainant are true:
- Ciming Biology is the predecessor of the issuer, and the prospectus (pre-disclosure draft) concealed the true process of the company's development history, business, and source of funds.
- Without the consent of Li Gangyi, his 10% equity in Ciming Biology was transferred to Han Xiaohong. He filed lawsuits against Han Xiaohong and Hu Bo in Chaoyang District People's Court in May 2011 for "equity transfer disputes" and "company resolution cancellation disputes," and the court has accepted the cases.